For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...
Corrections: This story was updated to clarify the findings of clinical trials and out-of-pocket cost information. As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results